Acute Idiopathic Maculopathy Following SARS-CoV-2 Vaccination.

Isaac D BleicherDaniel BrillFrances Wu Lucia Sobrin Nimesh A Patel

Published in: Ocular immunology and inflammation (2022)

A 49-year-old man presented with acute unilateral blurred vision one week after SARS-CoV-2 vaccination. A unilateral serous detachment of the macula, intraretinal hemorrhages, vitritis, and anterior chamber cell was found. Diagnostic testing was negative for infectious and inflammatory causes, and a diagnosis of acute idiopathic maculopathy (AIM) was made. Symptoms and serous detachment resolved over 12 weeks, with residual retinal pigment epithelial changes consistent with the disease course. AIM is a rare diagnosis that presented in close proximity to SARS-CoV-2 vaccination without evidence of coxsackievirus infection. Further research is necessary to clarify an association between this vaccine and uveitis.

Keyphrases

sars cov
liver failure
respiratory failure
respiratory syndrome coronavirus
high grade
drug induced
aortic dissection
oxidative stress
hepatitis b virus
randomized controlled trial
intensive care unit
coronavirus disease
study protocol
acute respiratory distress syndrome
placebo controlled